Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > BTIG Initiates Coverage of PMN

View:

Post by bball67 on Oct 02, 2023 8:20pm

BTIG Initiates Coverage of PMN

Late this afternoon BTIG initiated coverage of PMN in a 45 page report with a Buy Rating and an $8 price target.

148

Comment

Comment by G1945V on Oct 03, 2023 6:35am

Are you able to post the BTIG link on PMN? TIA G1945V

Comment

Comment by BottomBroker on Oct 03, 2023 9:10am

https://www.streetinsider.com/Analyst+Comments/BTIG+Starts+ProMIS+Neurosciences+%28PMN%29+at+Buy/22227157.html This help?

Comment

Comment by retiredcop on Oct 03, 2023 11:04am

Lets actually go to the full report by BTIG and see why they are intiating coverage High-Engineering Player Developing Both Active and Passive Immune Therapeutics for Neurodegeneration. Initiating at Buy with a $8 PT (bluematrix.com)

100

Comment

Comment by BottomBroker on Oct 03, 2023 12:00pm

Thanks RC.

Comment

Comment by BottomBroker on Oct 03, 2023 12:13pm

So if I'm reading this right (and maybe I'm not), they're got a target of $8, based on the results of Phase 1A trials, which are due at the end of this year?

Comment